5258 related articles for article (PubMed ID: 6159079)
1. Relative pulmonary toxicity and antitumor effects of two new bleomycin analogs, pepleomycin and tallysomycin A.
Sikic BI; Siddik ZH; Gram TE
Cancer Treat Rep; 1980; 64(4-5):659-67. PubMed ID: 6159079
[TBL] [Abstract][Full Text] [Related]
2. Improved therapeutic index of bleomycin when administered by continuous infusion in mice.
Sikic BI; Collins JM; Mimnaugh EG; Gram TE
Cancer Treat Rep; 1978 Dec; 62(12):2011-7. PubMed ID: 87269
[TBL] [Abstract][Full Text] [Related]
3. Pulmonary toxicity induced by pepleomycin 3-[(S)-1'-phenylethylamino] propylamino-bleomycin.
Shinkai T; Saijo N; Tominaga K; Eguchi K; Shimizu E; Shibuya M; Shimabukuro Z; Koketsu H; Nakajima T; Niitani H
Jpn J Clin Oncol; 1983 Jun; 13(2):395-410. PubMed ID: 6193296
[TBL] [Abstract][Full Text] [Related]
4. A comparison of the pulmonary toxicity and chemotherapeutic activity of bleomycin-BAPP to bleomycin and pepleomycin.
Ginsburg E; Gram TE; Trush MA
Cancer Chemother Pharmacol; 1984; 12(2):111-5. PubMed ID: 6199131
[TBL] [Abstract][Full Text] [Related]
5. Pulmonary toxicity studies of bleomycin and talisomycin.
Schlein A; Schurig JE; Baca C; Bradner WT; Crooks ST
Cancer Treat Rep; 1981; 65(3-4):291-7. PubMed ID: 6165468
[TBL] [Abstract][Full Text] [Related]
6. [Therapeutic effect of an antineoplastic agent (peplomycin) adsorbed on activated charcoal (PEP-AC)].
Ekimoto H; Yamashita T; Takahashi K; Matsuda A; Nagahama F
Gan To Kagaku Ryoho; 1982 Aug; 9(8):1380-6. PubMed ID: 6191713
[TBL] [Abstract][Full Text] [Related]
7. [Changes of anticancer activity and pulmonary toxicity of bleomycins in differences of administration schedules and routes in mice].
Ekimoto H; Takahashi K; Matsuda A; Umezawa H
Gan To Kagaku Ryoho; 1984 Apr; 11(4):853-7. PubMed ID: 6202241
[TBL] [Abstract][Full Text] [Related]
8. [An experimental study on the anti-cancer effects of bleomycin, depot bleomycin in oil and peplomycin (author's transl)].
Kaneda T; Fujimoto Y; Ueda M; Shikimori M; Taguchi N; Hiraiwa K
Nihon Gan Chiryo Gakkai Shi; 1981 Oct; 16(6):1303-9. PubMed ID: 6174651
[No Abstract] [Full Text] [Related]
9. Biological evaluation of mitoxantrone dihydrochloride synthesized by a new method. I. Acute toxicity and antitumor activity in mouse transplantable tumor systems.
Matuszyk J; Kuśnierczyk H; Radzikowski C
Arch Immunol Ther Exp (Warsz); 1989; 37(1-2):77-88. PubMed ID: 2619512
[TBL] [Abstract][Full Text] [Related]
10. Antitumor action of pyran copolymer and tilorone against Lewis lung carcinoma and B-16 melanoma.
Morahan PS; Munson JA; Baird LG; Kaplan AM; Regelson W
Cancer Res; 1974 Mar; 34(3):506-11. PubMed ID: 4812258
[No Abstract] [Full Text] [Related]
11. Recent studies on antibiotics and small molecular immunomodulators with potential usefulness in treating lung cancer: Part I - Antitumor antibiotics and their derivatives.
Umezawa H
Int J Clin Pharmacol Ther Toxicol; 1982 Jan; 20(1):12-8. PubMed ID: 6173340
[TBL] [Abstract][Full Text] [Related]
12. Tallysomycin, a new antitumor antibiotic complex related to bleomycin. III. Antitumor activity of tallysomycins A and B.
Imanishi H; Ohbayashi M; Nishiyama Y; Kawaguchi H
J Antibiot (Tokyo); 1978 Jul; 31(7):667-74. PubMed ID: 80402
[TBL] [Abstract][Full Text] [Related]
13. The in vitro and in vivo antitumor effects of pepleomycin alone or in combination with radiation.
Sakamoto K; Komatsu K; Matsumoto Y
Radiat Res; 1985 May; 102(2):224-31. PubMed ID: 2416000
[TBL] [Abstract][Full Text] [Related]
14. Tallysomycin S10b: experimental antitumor activity and toxicity.
Schurig JE; Rose WC; Hirth RS; Schlein A; Huftalen JB; Florczyk AP; Bradner WT
Cancer Chemother Pharmacol; 1984; 13(3):164-70. PubMed ID: 6207948
[TBL] [Abstract][Full Text] [Related]
15. Antitumor activity evaluation of bromine-substituted analogues of ifosfamide. I. Stereodifferentiation of biological effects and selection of the most potent compounds.
Glazman-Kuśnierczyk H; Matuszyk J; Radzikowski C
Immunopharmacol Immunotoxicol; 1992; 14(4):883-911. PubMed ID: 1294626
[TBL] [Abstract][Full Text] [Related]
16. Enzyme immunoassay for pepleomycin, a new bleomycin analog.
Fujiwara K; Yasuno M; Kitagawa T
Cancer Res; 1981 Oct; 41(10):4121-6. PubMed ID: 6169433
[TBL] [Abstract][Full Text] [Related]
17. [Bleomycin, a new antibiotic possessing antitumor properties].
Vermel' EM
Vopr Onkol; 1972; 18(9):85-93. PubMed ID: 4126161
[No Abstract] [Full Text] [Related]
18. [Chemotherapy of malignant melanoma].
Ishihara K; Yamazaki N; Asano K
Gan To Kagaku Ryoho; 1993 Aug; 20(10):1287-92. PubMed ID: 7688498
[TBL] [Abstract][Full Text] [Related]
19. [Antineoplastic drug-induced pneumonitis-fibrosis].
Oizumi K; Nakai Y; Konno K
Gan No Rinsho; 1984 Jul; 30(9 Suppl):1217-24. PubMed ID: 6206254
[TBL] [Abstract][Full Text] [Related]
20. Preclinical antitumor efficacy of the polyamine analogue N1, N11-diethylnorspermine administered by multiple injection or continuous infusion.
Bernacki RJ; Oberman EJ; Seweryniak KE; Atwood A; Bergeron RJ; Porter CW
Clin Cancer Res; 1995 Aug; 1(8):847-57. PubMed ID: 9816054
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
